Hetrombopag
- Generic Name
- Hetrombopag
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H22N4O5
- CAS Number
- 1257792-41-8
- Unique Ingredient Identifier
- 9WGT51BDDL
- Background
Hetrombopag is under investigation in clinical trial NCT03976882 (Hetrombopag for the Treatment of Chemotherapy-induced Thrombocytopenia in Subjects With Malignancy.).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath